European Medicines Agency (EMA) provides recommendations on compassionate use of remdesivir for COVID-19 in the European Union

The EMA has given recommendations on how the investigational antiviral remdesivir should be used for treating COVID-19. In addition to describing which patients may benefit, the recommendations explain how to use remdesivir and give preliminary information on its safety.


European Medicines Agency